Publication | Open Access

Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors

Liver FibrosisPathologyFatty Liver DiseaseMetabolic SyndromeFollow-up StudyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseHepatotoxicityHepatology FibrosisHealth SciencesLiver PhysiologyHepatology InflammationPharmacologyDrug-induced Liver InjuryHepatologyDiabetesSodium-glucose Co-transporter-2 InhibitorsLiver DiseaseMedicine